Suprasellar pilocytic astrocytoma in an adult with hemorrhage and leptomeningeal dissemination: case report and review of literature  by Soliman, Radwa K. et al.
ww.sciencedirect.com
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 4 1 1e4 1 8Available online at wScienceDirect
journal homepage: ht tp: / /E lsevier .com/locate/radcrCase Report
Suprasellar pilocytic astrocytoma in an adult with
hemorrhage and leptomeningeal dissemination: case report
and review of literatureRadwa K. Soliman MDa,*, Caterina Budai PGDiRa, Pravin Mundada FRCR, DMREa,
Bakar Aljohani EDiRa, Elisabeth J. Rushing MDb, Spyros S. Kollias MDa
a Institute of Neuro-Radiology, University of Zu¨rich, University Hospital Zu¨rich, FrauenKlinkstrasse 10 CH-8091, Zu¨rich, Switzerland
b Institute of Neuro-Pathology, University of Zu¨rich, University Hospital Zu¨rich, Schmelzbergstrasse 12-8091 Zu¨rich, Switzerlanda r t i c l e i n f o
Article history:
Received 18 June 2016
Received in revised form
8 August 2016
Accepted 21 August 2016
Available online 29 September 2016
Keywords:
Pilocytic astrocytoma
Leptomeningeal dissemination
HemorrhageCompeting Interests: The authors have dec
* Corresponding author.
E-mail address: radwa.soliman@yahoo.co
http://dx.doi.org/10.1016/j.radcr.2016.08.011
1930-0433/© 2016 the Authors. Published by
access article under the CC BY-NC-ND licena b s t r a c t
Pilocytic astrocytoma (PA) is a low-grade tumor. It has an excellent prognosis after total
resection. Leptomeningeal dissemination and hemorrhage are very rare to be associated
with PA and lead to unfavorable prognosis. A 35-year-old man was diagnosed with a
hemorrhagic suprasellar PA in 2006. Subsequent examination in 2007 revealed another
large subdural hemorrhagic lesion in the sacral region, which proved to be PA by histo-
pathologic assessment. Other leptomeningeal foci were discovered mainly at the cranio-
cervical junction. The patient underwent subtotal resection and received chemotherapy
with disease control for 7 years. Progression of the disseminated disease has recently
occurred; however, the patient is still alive with stable disease after radiotherapy. The
radiological features, management, and relevant literature are also presented. Our report
heightens the awareness of PA in the adult population and the importance of close sur-
veillance for the leptomeningeal spread, especially for sellar region tumors.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pilocytic astrocytoma (PA) is a low-grade tumor, classified
according to theWHOas grade I [1]. PA occursmost commonly
in children and young adults before the age of 20 years. About
17% occur in patients older than 30 years old [2,3]. It is asso-
ciated with an excellent prognosis with 10 years survival rate
reaching 95% after complete resection [4,5]. Imaging of PAlared that no competing
.uk (R.K. Soliman).
Elsevier Inc. under copy
se (http://creativecommooften reveals a cystic lesionwith an intensely enhancedmural
nodule occasionally accompanied by enhancement of thewall
of the cyst [6]. Less common, PA appears as a solid lesion,
either homogenous or heterogeneous, particularly when
localized in the hypothalamic region. Intratumoral hemor-
rhage and leptomeningeal dissemination (LD) are atypical
features of PA [6,7]. Intratumoral hemorrhage in PA is very
rare with only 32 cases being reported from 1977 to 2008 [2,8].interests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
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such as medulloblastoma, ependymoma, and glioblastoma,
a few case studies have investigated tumor dissemination in
PA. The first case of PAwith LDwas reported in 1976 [9], and by
2013, there were 60 cases [10]. We present an additional case
of PA in an adult patient with intratumoral hemorrhage
and LD.Case presentation
In January 2006, a 35-year-old man presented with symptoms
of increased intracranial pressure and the suspicion of ven-
triculoperitoneal (VP) shunt obstruction. A VP shunt had been
placed in 2000 to control hydrocephalus caused bymeningitis.
Computed tomography examination was performed and
revealed a hemorrhagic suprasellar lesion extending to the
right cerebellopontine angle cistern (Fig. 1). Magnetic reso-
nance imaging (MRI) revealed, in addition, prominent lep-
tomeningeal enhancing nodule at the craniocervical (C.C)
junction (Fig. 2). Subtotal resection of the suprasellar lesion
was performed, and histopathologic evaluation was consis-
tent with PA (WHO grade I). No further treatment was given at
that time, but regular follow-up MRI of the brain and spine
were recommended for the early detection of further
dissemination. In 2007, the residual suprasellar lesion was
shown in the MRI, and there was no evidence of further LD inFig. 1 e Noncontrast computed tomography: hyperdense
lesion in the suprasellar region (black star) with cystic
component, extending to the right prepontine space (black
arrow).the brain. Whereas, in the spine, MRI examination revealed a
large nonhomogenous lesion in the subdural space, at the
sacral region with some hemorrhagic components (Fig. 3).
Two months later, partial resection of the sacral lesion
through L5 laminectomy was performed. Pathologic exami-
nation again revealed histologic features typical for PA (Fig. 4).
The histologic specimen was submitted for a second opinion
at a Tumor Reference Center, and the diagnosis was recon-
firmed. Postoperatively, local irradiation was delivered to the
sacral mass. The patient then underwent one year of chemo-
therapy with temozolomide. Follow-up MRI examinations,
between 2008 and 2013, revealed a minimal increase in the
size of the residual suprasellar lesionwith a slight progression
of the LD, whereas the residual sacral lesion remained sta-
tionary. In 2014, however, therewas an evident increase in the
size of both the residual suprasellar and sacral lesions with
diffuse intracranial leptomeningeal spread (Figs. 5 and 6)
accompanied by progressive clinical deterioration. The pa-
tient then treated with craniospinal irradiation. He did well
after therapy. Follow-up MRI examinations, in 2015, revealed
good regression of the suprasellar and the leptomeningeal
disease (Fig. 7) with slow regression of the sacral mass.Discussion and review of literature
The present case of PA is notable for the age of the patient, a
35-year-old adult and the multifocal spread of the tumor. The
aim of this reviewwas to increase awareness of PA in the adult
population and to draw attention to the potential for lep-
tomeningeal spread.
In our case, the primary lesion was located in the supra-
sellar region, similar to most previously reported cases. In
fact, LD in the setting of PA usually occurs when the primary
tumor is found in the vicinity of cerebrospinal fluid (CSF)
spaces, such as, in the subarachnoid spaces or adjacent to
ventricular surfaces. Tumors in the hypothalamic and/or
chiasmatic region demonstrate the highest rate of dissemi-
nation, about 23-fold higher than PA in other areas [9,11,12].
Tumor cells in these locationsmay breach the leptomeningeal
or ependymal surfaces, and then spread along CSF flow
pathways [13e15]. As in the case of other tumors with a pre-
dilection for CSF dissemination, secondary deposits are pri-
marily found caudally in the spinal canal due to the effects of
gravity, and at the C.C junction, due to slower CSF flow in the
cisterna magna [16,17]. In accordance with the above, the
largest drop metastasis in our case was found in the sub-
arachnoid space in the sacral region, whereas the other LD
foci were in the region of the C.C junction. Other reports have
shown that dissemination occurs against gravity, in a cranial
rather than caudal direction. This usually occurs when the
primary PA is found in the spinal cord [16,18,19]. Tumor cells
in from a primary located caudally in the spinal cord may
spread cranially during the recumbent position. Intra-
parenchymal PAs rarely show CSF dissemination. In these
rare cases, the mechanism advanced for explaining the
dissemination is tumor cells spread through adjacent peri-
vascular spaces [14,20].
Fig. 2 e Noncontrast images: (A) sagittal T1WI, (B) axial T2WI. Postcontrast images: (C) coronal, (D) axial, and (E and F)
sagittal. They showed a mixed solid and cystic lesion located mainly in the suprasellar region with a rightward retroclival
extension. The lesion elicits isointense signal intensity (SI), to the brain parenchyma, on T1WI and hypointense SI on
T2WI, the cystic component showed a fluiddfluid level (black arrow) with SI indicative of a hemorrhagic content.
Associated partial encasement of the right cavernous sinus (white small arrow). Also, noted enhancing leptomeningeal
nodular thickening at the C.C junction (thick blue arrow). Nota Bene: artifact seen on axial images is due to the previously
placed VP shunt.
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Fig. 3 eMRI of the lumbar spine: (A) sagittal T1WI, (B) sagittal T2WI, and (C) sagittal postcontrast images. Figure shows large
subdural mixed solid andmultilobulated cystic components. There is fluidefluid level (white arrow) with faint hyperintense
on T1WI signal posteriorly (blue arrow), indicative of a hemorrhagic content. It shows thick irregular peripheral
enhancement.
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presence of concomitant multicentric disease, with no evi-
dence of spread from the primary tumor, rather than sec-
ondary multifocal spread. Although tumor manifestations
were present in both suprasellar and C.C regions at the time of
diagnosis, tumor progression at later stageswas characterized
by diffuse dissemination along the CSF pathways.
Surgical manipulation, whether subtotal resection or VP
shunt placement, is another important risk factor for tumor
dissemination in patients with PA. Surgical intervention may
facilitate the seeding of tumor cells in different locations or
open a pathway for tumor cell migration to the CSF spaces
[12,21]. Several cases of PA dissemination have been reported
after surgical intervention [17,22]. This is less likely the case in
our patient, since LD was already visible on the initial MRI
examination, before any surgical manipulation of the tumor.
The placed VP shunt could, however, be responsible for this
dissemination, though unlikely, as it had been placed 6 years
earlier to control hydrocephalus caused by meningitis. This is
in accordance with other previously reported cases, in which
LD was evident before any intervention [9,12].
In addition to the close proximity of tumor to CSF spaces
and spread secondary to iatrogenic manipulation, other
inherent biological properties, such as tumor consistency,
pattern of adhesiveness, and protease secretion,may facilitatethe invasion of ependymal surfaces and tumor fragmentation
with subsequent free flow and dissemination of the tumor
cells within the CSF [12,15,23].
Hemorrhagic components were evident in our case. Hem-
orrhage associated with PA is very rare with only 32 docu-
mented cases from 1997 to 2008 [2,8]. Hemorrhage in a PAmay
be considered as an additional risk factor for LD, as it may
potentiate adhesion of the tumor to the leptomeninges and
subsequent invasion.
It is well accepted that LD is more commonwithmalignant
neoplasms.
Malignant transformation of PA has been reported in the
literature, through several case studies [24e26]. It is thought
to be mostly radiation-induced in most instances [3,27].
Only rare examples of PA show spontaneous malignant
transformation [26]. LD can be associated with a potential
malignant transformation of PA. This is supported by some
reports that documented higher histologic grades in the
metastatic leptomeningeal foci [28,29]. However, this is not
the case in our patient, in which histologic evaluation of all
specimens failed to reveal evidence of anaplasia. Of note,
LD had been already observed at the time of the initial
diagnosis, before treatment. Most previously reported PAs
with LD lacked evidence of malignant transformation
[13,14,17].
Fig. 4 e Low-grade astrocytic neoplasm composed of small,
uniform clear cells embedded in a fibrillary matrix. Higher
magnification reveals aggregates of protein droplets and
eosinophilic granular bodies commonly found in PA.
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PMA can be distinguished from PA by the presence of a
prominent myxoid stroma, the angiocentric arrangement of
the neoplastic cells forming rosette-like structures, and the
absence of Rosenthal fibers and eosinophilic granules. PMA is
considered as a variant of PA, most often found in the hypo-
thalamus or optic pathways [3,6]. PMA ismore aggressive than
the classic PA and classified as WHO grade II [1]. Previous
reports have shown a strong association between PMA and LD
[22,30,31]. In addition, other reports indicate an association
between PMA and intratumoral hemorrhage [7,32], (25%) in
PMA compared with PA (8%) [33,34]. In our case, pilomyxoid
features were not present.
Molecular genetics studies showed that overexpression of
the epidermal growth factor receptor (EGFR), found on the
short arm of chromosome 7, is positively correlated with
aggressive tumor behavior [35,36]. In addition, it has beenreported that overexpression of EGFR is higher in low-grade
glioma associated with LD [16,37].
PA is more common in pediatric than in adult patients and
typically occurs between the age of 5 and 14 years old [4]. In
adults, PA tends to exhibit a less favorable prognosis [38] as
witnessed in our patient. Previous studies ascribe the poor
prognosis in older patients to the high rate of recurrence,
tumor progression, and frank malignant transformation
[24,39]. Interestingly, only 20% of previously reported 60 cases
of PA associated with LD were more than 15 years old. LD in
PA does not appear to correlate with an older age of the
patients.
The prognosis of PA, even with LD is more favorable than
for diffuse astrocytomas (WHO grades II-IV) [40], particularly
when there is no evidence of anaplasia. Mazloom et al., in a
retrospective review of 58 patients with PA with LD, reported
that the 5-year survival rate approached 55%. Few cases,
however, have shown longer survival [17,22], that may reach
20 years [22]. Several factors including the extent of the sur-
gical resection, adjuvant radiotherapy, and chemotherapy,
the age of the patient and location of the primary tumor play
a significant role in patient outcome. Therefore, early diag-
nosis and effective management are critical for long-term
survival. Optimal therapy for patients with PA accompanied
by LD remains controversial. Initial total resection of the
tumor remains the goal to reduce the risk of LD [15,41]. Close
long-term follow-up with regular MRI should facilitate early
detection of dissemination. The value of adjuvant chemo-
therapy and/or radiotherapy is variable in the previous
reports. To avoid long-term toxicity, radiotherapy is usually
not favored in young patients [40,42]. In this context, Bain
et al., in 2013, introduced proton therapy in the treatment of
dissemination in an attempt to eliminate the exit dose, with
radiation focused only to the craniospinal axis. In cases with
EGFR overexpression, EGFR inhibitors would represent useful
adjuvant therapy [16,43].
The treatment regimen in our case consisted of subtotal
resection, local irradiation to the sacral mass, and chemo-
therapy, with relatively effective disease control for 7 years.
However, the patient has recently developed progressive
dissemination, which has required additional radiotherapy.
The overall survival time is 9 years, and the patient remains
on follow-up.Conclusions
The diagnosis of PA in adults is rarely made preoperatively;
therefore, enhanced awareness is crucial to facilitate correct
diagnosis and management. The possibility of LD in cases of
PA should be considered when tumors are in close proximity
to CSF spaces, especially in the sellar region, and after subtotal
resection or VP shunt placement. The risk of LD is also
increased in cases of PMA or when features of anaplasia are
present. In addition, molecular genetic studies for over-
expression of EGFR may be predictive of an aggressive course.
Finally, spinal MRI is recommended whenever PA is found to
be associated with the above risk factors.
Fig. 5 e MRI of the brain (A, B) axial postcontrast T1WI. (C) Sagittal postcontrast T1WI, (D) coronal postcontrast T1WI.
Progressive course evident by increase the size of the suprasellar lesion, diffuse LD appears in Meckel’s caves,
cerebellopontine angles (white long arrows), anterior to the upper cervical cord (blue arrow), in the ependymal surface of the
fourth ventricle (white short arrow), and in the aqueduct of sylvius (short black arrow) as well as along the vermis (long
black arrow).
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Fig. 6 eMRI of the spine: (A) sagittal T1WI, (B) sagittal postcontrast image. Figure shows a progressive course evident by an
increase in the size of the, partially resected, subdural lesion (m) at the sacral region. The lesion appears more solid
compared to the preoperative images shown in Figure 3.
Fig. 7 e MRI of the brain: sagittal postcontrast T1WI.
Figure shows reduction in the size of the suprasellar lesion
and marked resolution of the diffuse LD previously shown
in Figure 6 with only noted small focal enhancing nodules
in the prepontine cistern and anterior to the spinal cord
(white arrow heads).
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